Kara Lake Lynch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kara Lake Lynch has a total of 261 co-authors. Here are the top co-authors by number of shared publications:
- Alan H. B. Wu
Department of Laboratory Medicine, University of California, San Francisco, CA 94143, USA
15 shared publications Alan H.B. Wu
Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
7 shared publications- Elise D. Riley
Department of Medicine, University of California, San Francisco, San Francisco, USA
5 shared publications - Cassandra Yun
Department of Laboratory Medicine, University of California, San Francisco, CA, USA
4 shared publications - Adina Badea
Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, 02912, United States
3 shared publications Alan H. B. Wu
Department of Laboratory Medicine, University of California, San Francisco, USA
3 shared publications
Latest Publications
- 9 September 2026
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
CD4 Count and CD4/CD8 Ratio Impact Antibody Responses to COVID-19 mRNA Booster Vaccination in People with HIV on Suppressive ART
Objective: To evaluate the durability of SARS-CoV-2–specific humoral and cellular immune responses after booster vaccination in people living with HIV (PLWH) in a prospective longitudinal cohort study. Methods: We analyzed 46 PLWH with no prior history of SARS-CoV-2 infection who received a booster dose. Anti-receptor-binding domain (RBD) IgG concentrations, neutralization titers, and T cell responses were measured over time. The associations between CD4+ T cell count and CD4/CD8 ratio with antibody dynamics were assessed, adjusting for age, sex, and vaccine type. Results: Anti-RBD IgG and neutralization titers declined significantly over time. Participants with CD4+ T cell counts <500 cells/μL exhibited a 3-fold faster decline in anti-RBD IgG compared to those with ≥500 cells/μL. Neutralization capacity declined similarly across both groups, suggesting that CD4+ T cell count primarily influences antibody quantity rather than functional quality. A lower CD4/CD8 ratio was independently associated with reduced baseline IgG concentrations but did not influence the rate of antibody decay. In a subset of 30 participants, a lower CD4/CD8 ratio was also associated with altered follicular helper (Tfh) CD4+ T cell frequencies and faster decline of Spike-specific Tfh over time. Conclusions: CD4+ T cell count influences antibody persistence, while the CD4/CD8 ratio affects initial antibody magnitude and Tfh cell frequencies, highlighting complementary roles in shaping vaccine responses in PLWH.
- 9 September 2026
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
CD4 Count and CD4/CD8 Ratio Impact Antibody Responses to COVID-19 mRNA Booster Vaccination in People with HIV on Suppressive ART
Objective: To evaluate the durability of SARS-CoV-2–specific humoral and cellular immune responses after booster vaccination in people living with HIV (PLWH) in a prospective longitudinal cohort study. Methods: We analyzed 46 PLWH with no prior history of SARS-CoV-2 infection who received a booster dose. Anti-receptor-binding domain (RBD) IgG concentrations, neutralization titers, and T cell responses were measured over time. The associations between CD4+ T cell count and CD4/CD8 ratio with antibody dynamics were assessed, adjusting for age, sex, and vaccine type. Results: Anti-RBD IgG and neutralization titers declined significantly over time. Participants with CD4+ T cell counts <500 cells/μL exhibited a 3-fold faster decline in anti-RBD IgG compared to those with ≥500 cells/μL. Neutralization capacity declined similarly across both groups, suggesting that CD4+ T cell count primarily influences antibody quantity rather than functional quality. A lower CD4/CD8 ratio was independently associated with reduced baseline IgG concentrations but did not influence the rate of antibody decay. In a subset of 30 participants, a lower CD4/CD8 ratio was also associated with altered follicular helper (Tfh) CD4+ T cell frequencies and faster decline of Spike-specific Tfh over time. Conclusions: CD4+ T cell count influences antibody persistence, while the CD4/CD8 ratio affects initial antibody magnitude and Tfh cell frequencies, highlighting complementary roles in shaping vaccine responses in PLWH.
- 1 July 2026
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (11) , 1192-1200
Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer
Background: Comprehensive drug testing (CDT) by liquid chromatography–high-resolution mass spectrometry (LC-HRMS) is a valuable method for evaluating clinical samples for unknown toxicological agents. However, the sensitivity of CDT methods is generally lower than targeted approaches. A novel MS technology, linear ion trap (LIT)-pulsing, has demonstrated improved sensitivity in proteomics and metabolomics applications, but its utility and interactions with different HRMS acquisition types, such as information-dependent acquisition (IDA) and sequential window acquisition of all theoretical fragment ion spectra (SWATH), have not been explored in small molecule analysis. Methods: CDT methods utilizing both IDA and SWATH acquisition were developed on a quadrupole time-of-flight (QTOF) instrument featuring LIT pulsing. Limits of detection (LODs) and process efficiencies were estimated for 150 toxicological agents. Additionally, 101 patient urine specimens were used to compare both methods against an established clinical CDT without LIT-pulsing. Selectivity was assessed using a targeted LC-HRMS method. Results: LIT-pulsed SWATH acquisition improved detection of toxicological agents compared to LIT-pulsed IDA, with a median 5-fold reduction to measured LODs and an average 5.9% reduction to matrix suppression. In authentic patient samples, LIT-pulsed IDA and SWATH acquisition identified 889 and 1083 toxicological agents compared to 835 using IDA without LIT-pulsing. The estimated selectivity of LIT-pulsed IDA was improved compared to conventional IDA acquisition, but SWATH acquisition demonstrated significant nonselectivity. Conclusion: LIT-pulsing improves the sensitivity and selectivity of CDT methods. The largest improvements to sensitivity are observed using SWATH acquisition; however, these gains are accompanied by reduced selectivity. This highlights the need for careful validation of SWATH CDT methods to ensure high clinical performance.
- 1 July 2026
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (11) , 1192-1200
Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer
Background: Comprehensive drug testing (CDT) by liquid chromatography–high-resolution mass spectrometry (LC-HRMS) is a valuable method for evaluating clinical samples for unknown toxicological agents. However, the sensitivity of CDT methods is generally lower than targeted approaches. A novel MS technology, linear ion trap (LIT)-pulsing, has demonstrated improved sensitivity in proteomics and metabolomics applications, but its utility and interactions with different HRMS acquisition types, such as information-dependent acquisition (IDA) and sequential window acquisition of all theoretical fragment ion spectra (SWATH), have not been explored in small molecule analysis. Methods: CDT methods utilizing both IDA and SWATH acquisition were developed on a quadrupole time-of-flight (QTOF) instrument featuring LIT pulsing. Limits of detection (LODs) and process efficiencies were estimated for 150 toxicological agents. Additionally, 101 patient urine specimens were used to compare both methods against an established clinical CDT without LIT-pulsing. Selectivity was assessed using a targeted LC-HRMS method. Results: LIT-pulsed SWATH acquisition improved detection of toxicological agents compared to LIT-pulsed IDA, with a median 5-fold reduction to measured LODs and an average 5.9% reduction to matrix suppression. In authentic patient samples, LIT-pulsed IDA and SWATH acquisition identified 889 and 1083 toxicological agents compared to 835 using IDA without LIT-pulsing. The estimated selectivity of LIT-pulsed IDA was improved compared to conventional IDA acquisition, but SWATH acquisition demonstrated significant nonselectivity. Conclusion: LIT-pulsing improves the sensitivity and selectivity of CDT methods. The largest improvements to sensitivity are observed using SWATH acquisition; however, these gains are accompanied by reduced selectivity. This highlights the need for careful validation of SWATH CDT methods to ensure high clinical performance.
- 5 March 2026
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (3) , 335-336
Commentary on Increased Salicylate Concentration in a Patient Reporting No Aspirin Use
- 5 March 2026
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (3) , 335-336
Commentary on Increased Salicylate Concentration in a Patient Reporting No Aspirin Use
- Open Access
- 1 January 2026
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 39 (1)
Publishing Without Barriers: A Vision for What Comes Next
JMSACL has partnered with Stanford University Press and moved to a non-profit, open access model to better support trustworthy, widely available research in laboratory medicine. Publishing and reading will remain free in 2026, with institutions helping fund open access from 2027. MSACL will retain ownership of the journal, meaning all existing relationships (e.g., PubMed Central indexing) and scoring histories (e.g., Impact Factor) will remain intact. The use of AI in collaboration with human oversight to expedite review speed, while maintaining the quality of published content, will be evaluated for incorporation into the publishing workflow.
- 1 January 2026
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 39 (1)
Open AccessPublishing Without Barriers: A Vision for What Comes Next
JMSACL has partnered with Stanford University Press and moved to a non-profit, open access model to better support trustworthy, widely available research in laboratory medicine. Publishing and reading will remain free in 2026, with institutions helping fund open access from 2027. MSACL will retain ownership of the journal, meaning all existing relationships (e.g., PubMed Central indexing) and scoring histories (e.g., Impact Factor) will remain intact. The use of AI in collaboration with human oversight to expedite review speed, while maintaining the quality of published content, will be evaluated for incorporation into the publishing workflow.
- 10 December 2024
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 71 (2) , 230-231
New Insights into Xylazine Pharmacokinetics in Humans
- 10 December 2024
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 71 (2) , 230-231
New Insights into Xylazine Pharmacokinetics in Humans
- Open Access
- 24 September 2024
- Published by River Publishers in International Journal of Translational Science
- p. 221-256
Chrono-Nutrition: Understanding the Interplay Between Circadian Rhythms and Personalized Nutrition
Chrono-nutrition, a concept emerging from the integration of chronobiology and nutrition sciences, investigates the timing of food intake in alignment with the body’s circadian rhythms. This interplay between dietary patterns and biological rhythms has garnered significant attention in recent years due to its potential implications for health and disease. In this comprehensive review, we explore the key findings from studies in the last decade on chrono-nutrition, focusing on its role in cardiovascular health, diabetes management, glucose metabolism, and the influence of sex, socioeconomic factors, and cultural diversity. The intricate dance between the molecular circadian clock and the gut microbiome is a fascinating area of study in modern biology. Both systems are integral to the regulation of metabolic processes, responding to dietary inputs and environmental cues to optimize the host’s adaptability and survival. This review delves into the dynamic interplay between circadian rhythms and the gut microbiome, exploring their mutual influence and the implications for human health.
- 24 September 2024
- Published by River Publishers in International Journal of Translational Science
- p. 221-256
Open AccessChrono-Nutrition: Understanding the Interplay Between Circadian Rhythms and Personalized Nutrition
Chrono-nutrition, a concept emerging from the integration of chronobiology and nutrition sciences, investigates the timing of food intake in alignment with the body’s circadian rhythms. This interplay between dietary patterns and biological rhythms has garnered significant attention in recent years due to its potential implications for health and disease. In this comprehensive review, we explore the key findings from studies in the last decade on chrono-nutrition, focusing on its role in cardiovascular health, diabetes management, glucose metabolism, and the influence of sex, socioeconomic factors, and cultural diversity. The intricate dance between the molecular circadian clock and the gut microbiome is a fascinating area of study in modern biology. Both systems are integral to the regulation of metabolic processes, responding to dietary inputs and environmental cues to optimize the host’s adaptability and survival. This review delves into the dynamic interplay between circadian rhythms and the gut microbiome, exploring their mutual influence and the implications for human health.
- 5 April 2024
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 55 (5) , 609-614
Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage
Background: Serum level of microRNA-122 (miR-122) has been reported as a sensitive diagnostic biomarker for detecting liver injury, comparable to the aminotransferases. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities are increased in other conditions, such as acute skeletal muscle injury (ASMI). We determined whether miR-122 is nonspecifically increased in patients suffering from ASMI. Methods: We measured ALT, AST, creatine kinase (CK), and miR-122 in 3 groups: healthy controls (n = 24), patients with ASMI (total n = 29, 11 with recreational drug use and 18 without recreational drug use), and patients with acute liver injury (ALI; n = 14). Results: Levels of ALT, AST, and CK increased 83%, 97%, and 100% for patients with ASMI and 100% for all 3 enzymes in ALI patients. In contrast, miR-122 increased in 34% of patients with ASMI (44.4% with recreational drug use and 18.2% without recreational drug use) and 100% of ALI patients. In 2 drug-induced liver injury cases, miR-122 increased about 12-24 hours before ALT and AST. Conclusion: Recreational drug misuse is associated with both rhabdomyolysis and drug-induced liver injury (DILI). The traditional liver function markers AST and ALT were nonspecifically increased in the majority of patients with ASMI. miR-122 is only increased in patients at risk for DILI and demonstrates superior specificity for liver injury.
- 5 April 2024
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 55 (5) , 609-614
Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage
Background: Serum level of microRNA-122 (miR-122) has been reported as a sensitive diagnostic biomarker for detecting liver injury, comparable to the aminotransferases. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities are increased in other conditions, such as acute skeletal muscle injury (ASMI). We determined whether miR-122 is nonspecifically increased in patients suffering from ASMI. Methods: We measured ALT, AST, creatine kinase (CK), and miR-122 in 3 groups: healthy controls (n = 24), patients with ASMI (total n = 29, 11 with recreational drug use and 18 without recreational drug use), and patients with acute liver injury (ALI; n = 14). Results: Levels of ALT, AST, and CK increased 83%, 97%, and 100% for patients with ASMI and 100% for all 3 enzymes in ALI patients. In contrast, miR-122 increased in 34% of patients with ASMI (44.4% with recreational drug use and 18.2% without recreational drug use) and 100% of ALI patients. In 2 drug-induced liver injury cases, miR-122 increased about 12-24 hours before ALT and AST. Conclusion: Recreational drug misuse is associated with both rhabdomyolysis and drug-induced liver injury (DILI). The traditional liver function markers AST and ALT were nonspecifically increased in the majority of patients with ASMI. miR-122 is only increased in patients at risk for DILI and demonstrates superior specificity for liver injury.
- Open Access
- 1 November 2023
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 30, 38-44
Comparison of liquid chromatography-high-resolution tandem mass spectrometry (MS2) and multi-stage mass spectrometry (MS3) for screening toxic natural products
Liquid chromatography-high-resolution mass spectrometry (LC-HR-MS) has emerged as a powerful analytical technology for compound screening in clinical toxicology. To evaluate the potential of LC-HR-MS3 in detecting toxic natural products, a spectral library of 85 natural products (79 alkaloids) that contains both MS2 and MS3 mass spectra was constructed and used to identify the natural products. Samples were analyzed using an LC-HR-MS3 method and the generated data were matched to the spectral library to identify the natural products. To test the performance of the LC-HR-MS3 method in different sample matrices, the 85 natural product standards were divided into three groups to separate structural isomers and avoid ion suppression effects caused by co-elution of multiple analytes. The grouped analytes were spiked into drug-free serum and drug-free urine to produce contrived clinical samples. The compound identification results of the 85 natural products in urine and serum samples were obtained. The match scores using both MS2 and MS3 mass spectra and those using only MS2 mass spectra were compared at 10 different analyte concentrations. The two types of data analysis provided identical identification results for the majority of the analytes (96% in serum, 92% in urine), whereas, for the remaining analytes, the MS2-MS3 tree data analysis had better performance in identifying them at lower concentrations. This study shows that in comparison to LC-HR-MS (MS2), LC-HR-MS3 can increase the performance in identification of a small group of the toxic natural products tested in serum and urine specimens.
- 1 November 2023
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 30, 38-44
Open AccessComparison of liquid chromatography-high-resolution tandem mass spectrometry (MS2) and multi-stage mass spectrometry (MS3) for screening toxic natural products
Liquid chromatography-high-resolution mass spectrometry (LC-HR-MS) has emerged as a powerful analytical technology for compound screening in clinical toxicology. To evaluate the potential of LC-HR-MS3 in detecting toxic natural products, a spectral library of 85 natural products (79 alkaloids) that contains both MS2 and MS3 mass spectra was constructed and used to identify the natural products. Samples were analyzed using an LC-HR-MS3 method and the generated data were matched to the spectral library to identify the natural products. To test the performance of the LC-HR-MS3 method in different sample matrices, the 85 natural product standards were divided into three groups to separate structural isomers and avoid ion suppression effects caused by co-elution of multiple analytes. The grouped analytes were spiked into drug-free serum and drug-free urine to produce contrived clinical samples. The compound identification results of the 85 natural products in urine and serum samples were obtained. The match scores using both MS2 and MS3 mass spectra and those using only MS2 mass spectra were compared at 10 different analyte concentrations. The two types of data analysis provided identical identification results for the majority of the analytes (96% in serum, 92% in urine), whereas, for the remaining analytes, the MS2-MS3 tree data analysis had better performance in identifying them at lower concentrations. This study shows that in comparison to LC-HR-MS (MS2), LC-HR-MS3 can increase the performance in identification of a small group of the toxic natural products tested in serum and urine specimens.